Early Identification of the Association Between Rofecoxib and Cardiovascular Adverse Events Using real-World Data from the UK: A Case-Control Study

被引：0
|
作者：
Moslemzadeh, Donya [1 ]
Abtahi, Shahab [2 ]
Souverein, Patrick C. [2 ]
Heerdink, Eibert Rob [2 ]
Klungel, Olaf H. [2 ]
机构：
[1] Univ Utrecht, Utrecht, Netherlands
[2] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
536
引用
收藏
页码：222 / 222
页数：1
相关论文
共 50 条
  • [41] Long-term Cardiovascular Adverse Events Induced by Fluoroquinolones: A Retrospective Case-control Study
    Algaidi, Shaima H.
    Alghamdi, Doaa I.
    Algheffari, Shimaa G.
    Alzahrani, Renad A.
    Thabit, Abrar K.
    Hafiz, Awatif M.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2023, 82 (05) : 400 - 406
  • [42] Real-world data of the association between quality of life using the EuroQol 5 Dimension 5 Level utility value and adverse events for outpatient cancer chemotherapy
    Hirose, Chiemi
    Fujii, Hironori
    Iihara, Hirotoshi
    Ishihara, Masashi
    Nawa-Nishigaki, Minako
    Kato-Hayashi, Hiroko
    Ohata, Koichi
    Sekiya, Kumiko
    Kitahora, Mika
    Matsuhashi, Nobuhisa
    Takahashi, Takao
    Okuda, Kumiko
    Naruse, Masayo
    Ishihara, Takuma
    Sugiyama, Tadashi
    Yoshida, Kazuhiro
    Suzuki, Akio
    SUPPORTIVE CARE IN CANCER, 2020, 28 (12) : 5943 - 5952
  • [43] Real-world data of the association between quality of life using the EuroQol 5 Dimension 5 Level utility value and adverse events for outpatient cancer chemotherapy
    Chiemi Hirose
    Hironori Fujii
    Hirotoshi Iihara
    Masashi Ishihara
    Minako Nawa-Nishigaki
    Hiroko Kato-Hayashi
    Koichi Ohata
    Kumiko Sekiya
    Mika Kitahora
    Nobuhisa Matsuhashi
    Takao Takahashi
    Kumiko Okuda
    Masayo Naruse
    Takuma Ishihara
    Tadashi Sugiyama
    Kazuhiro Yoshida
    Akio Suzuki
    Supportive Care in Cancer, 2020, 28 : 5943 - 5952
  • [44] Abrocitinib-associated adverse events: a real-world pharmacovigilance study using the FAERS database
    Sun, Yu
    Xu, Tao
    Zhu, Suyan
    Xu, Hongbin
    EXPERT OPINION ON DRUG SAFETY, 2025, 24 (02) : 233 - 239
  • [45] Assessment of adverse events associated with remdesivir use for coronavirus disease 2019 using real-world data
    Singh, Anika
    Kamath, Ashwin
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (12) : 1559 - 1564
  • [46] GASTROINTESTINAL ADVERSE EVENTS IN LUNG CANCER PATIENTS TREATED WITH IPILIMUMAB AND NIVOLUMAB USING REAL-WORLD DATA
    Zhao, Y.
    Bian, J.
    Guo, Y.
    VALUE IN HEALTH, 2022, 25 (07) : S591 - S591
  • [47] Relationship of adverse events to quality of anticoagulation control in atrial fibrillation patients with diabetes: real-world data from the FANTASIIA Registry
    Garcia-Fernandez, Amaya
    Esteve-Pastor, Maria Asuncion
    Roldan-Rabadan, Inmaculada
    Muniz, Javier
    Ruiz Ortiz, Martin
    Cequier, Angel
    Bertomeu-Martinez, Vicente
    Badimon, Lina
    Otero, Deborah
    Anguita, Manuel
    Lip, Gregory Y. H.
    Marin, Francisco
    ANNALS OF MEDICINE, 2020, 52 (06) : 300 - 309
  • [48] Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States
    Jain, P.
    Bugarin, J. Gutierrez
    Guha, A.
    Jain, C.
    Patil, N.
    Shen, T.
    Stanevich, I.
    Nikore, V.
    Margolin, K.
    Ernstoff, M.
    Velcheti, V.
    Barnholtz-Sloan, J.
    Dowlati, A.
    ESMO OPEN, 2021, 6 (05)
  • [49] Calcium Channel Blockers in Secondary Cardiovascular Prevention and Risk of Acute Events: Real-World Evidence from Nested Case-Control Studies on Italian Hypertensive Elderly
    Bettiol, Alessandra
    Lucenteforte, Ersilia
    Vannacci, Alfredo
    Lombardi, Niccolo
    Onder, Graziano
    Agabiti, Nera
    Vitale, Cristiana
    Trifiro, Gianluca
    Corrao, Giovanni
    Roberto, Giuseppe
    Mugelli, Alessandro
    Chinellato, Alessandro
    CLINICAL DRUG INVESTIGATION, 2017, 37 (12) : 1165 - 1174
  • [50] Real-world experience of carfilzomib-associated cardiovascular adverse events: SEER-Medicare data set analysis
    Bishnoi, Rohit
    Xie, Zhigang
    Shah, Chintan
    Bian, Jiang
    Murthy, Hemant S.
    Wingard, John R.
    Farhadfar, Nosha
    CANCER MEDICINE, 2021, 10 (01): : 70 - 78
12345